The Limb Salvage Center

Filter Your Results

 

News

 

Intact Vascular Announces Positive 1-Year Data From TOBA III Clinical Trial

September 27, 2019 -- Intact Vascular, Inc. announced 1-year results of its TOBA III clinical trial, which achieved both primary and secondary endpoints. Marianne Brodmann, MD…

Post-PTA Dissection Repair in the Bifurcation Using the Tack Endovascular System®

Mohammad Laiq Raja, MD

September 2019—Atherosclerotic disease in the bifurcating femoral artery remains hostile anatomy for endovascular intervention. The angled ostia of the superficial femoral artery (SFA) and p…

Optimized PTA With Tack Salvage Following Rendezvous Subintimal SFA CTO Recanalization

John H. Rundback, MD

September 2019—PATIENT HISTORY A 62-year-old man presented with a 2-month history of worsening bilateral calf pain (worse in the left leg) when walking one block. He complained of numbnes…

MedAlliance Receives FDA Breakthrough Device Designation for Selution SLR Sirolimus-Eluting Balloon to Treat BTK Disease

September 25, 2019 -- MedAlliance announced that the FDA awarded Breakthrough Device designation status for the company's Selution SLR, a sustained limus-release drug-elut…

Six-Month Results Presented From TINTIN Trial of iVascular’s Luminor DCB and iVolution BMS

September 24, 2019 -- iVascular, based in Barcelona, Spain, announced that 6-month results of the TINTIN study were presented by Principal Investigator Koen Deloose, MD, at CI…

FDA Approves PROMISE II Pivotal Study of LimFlow System to Treat Chronic Limb-Threatening Ischemia

September 19, 2019 -- LimFlow SA, a France-based developer of minimally invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), announced that the F…

Orchestra BioMed’s Virtue SEB Receives FDA Breakthrough Device Designation for BTK Treatment of PAD

September 17, 2019 -- Orchestra BioMed, Inc., in partnership with Terumo Corporation, announced that the FDA has granted Breakthrough Device designation for its Virtue sirolim…

FDA Clears Rex Medical’s Revolution Peripheral Atherectomy System

September 12, 2019 -- Rex Medical, LP announced that it has received FDA 510(k) clearance for the Revolution peripheral atherectomy system. The Revolution device is indic…

 

advertisement

US Device Guide

The Endovascular Today Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.